Fate of the resting perfusion defect as assessed with technetium-99m methoxy-isobutyl-isonitrile single-photon emission computed tomography after successful revascularization in patients with healed myocardial infarction

C Altehoefer; J vom Dahl; B J Messmer; P Hanrath; U Buell

doi:10.1016/s0002-9149(97)89142-4

Fate of the resting perfusion defect as assessed with technetium-99m methoxy-isobutyl-isonitrile single-photon emission computed tomography after successful revascularization in patients with healed myocardial infarction

Am J Cardiol. 1996 Jan 1;77(1):88-92. doi: 10.1016/s0002-9149(97)89142-4.

Authors

C Altehoefer¹, J vom Dahl, B J Messmer, P Hanrath, U Buell

Affiliation

¹ Department of Nuclear Medicine, University Hospital, Rheinisch-Westfaelische Hochschule Aachen, Germany.

PMID: 8540466
DOI: 10.1016/s0002-9149(97)89142-4

Abstract

It is concluded that in patients with healed myocardial infarction, MIBI uptake at rest underestimates myocardial viability and may improve significantly if blood flow is restored. Patients with MIBI defects at rest may therefore take advantage of revascularization.

MeSH terms

Coronary Circulation
Female
Humans
Male
Myocardial Infarction / diagnostic imaging*
Myocardial Infarction / metabolism*
Myocardial Infarction / surgery
Myocardial Revascularization*
Myocardium / metabolism*
Prospective Studies
Rest / physiology
Technetium Tc 99m Sestamibi*
Tomography, Emission-Computed, Single-Photon / methods

Substances

Technetium Tc 99m Sestamibi